Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maggie J. Cox"'
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Janus kinase 2 (JAK2) inhibitors such as ruxolitinib have become standard-of-care therapy for patients with myeloproliferative neoplasms (MPNs); however, activation of alternate oncogenic pathways including nuclear factor kappa-light-chain-enhancer o
Externí odkaz:
https://doaj.org/article/0a734db388e74aec9b92f27dfac3ac37
Autor:
Tim Kong, LaYow Yu, Angelo B. A. Laranjeira, Daniel A. C. Fisher, Fan He, Maggie J. Cox, Stephen T. Oh
Publikováno v:
American Journal of Hematology.
Autor:
Tim Kong, Angelo B. A. Laranjeira, Kangning Yang, Daniel A. C. Fisher, LaYow Yu, Laure Poittevin De La Frégonnière, Anthony Z. Wang, Marianna B. Ruzinova, Jared S. Fowles, Mary C. Fulbright, Maggie J. Cox, Hamza Celik, Grant A. Challen, Sidong Huang, Stephen T. Oh
Publikováno v:
Nature Cancer.
Autor:
Fan He, Angelo B. A. Laranjeira, Tim Kong, Alice Liu, Katrina J. Ashworth, Nina M. Lasky, Daniel A. C. Fisher, Maggie J. Cox, Mary C. Fulbright, Lilian A. Heck, LaYow Yu, Stephen M. Sykes, Angelo D’Alessandro, Jorge Di Paola, Stephen T. Oh
Platelets from patients with myeloproliferative neoplasms (MPNs) exhibit a hyperreactive phenotype. Here, we found elevated P-selectin exposure and platelet-leukocyte aggregates indicating activation of platelets from essential thrombocythemia (ET) p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26935691079821923873ee2f8dd16d2f
https://doi.org/10.1101/2022.12.08.519689
https://doi.org/10.1101/2022.12.08.519689
Autor:
Tim, Kong, Angelo B A, Laranjeira, Kangning, Yang, Daniel A C, Fisher, LaYow, Yu, Laure, Poittevin De La Frégonnière, Anthony Z, Wang, Marianna B, Ruzinova, Jared S, Fowles, Mary C, Fulbright, Maggie J, Cox, Hamza, Celik, Grant A, Challen, Sidong, Huang, Stephen T, Oh
Publikováno v:
Nature cancer.
Myeloproliferative neoplasms (MPNs) exhibit a propensity for transformation to secondary acute myeloid leukemia (sAML), for which the underlying mechanisms remain poorly understood, resulting in limited treatment options and dismal clinical outcomes.